Germany Oncology Therapeutics Market: Segmented by Cancer type, Treatment type, End User - Growth, Trends, and Forecasts (2019 2028)
- Published Date: 2022-12-28
- Report ID: 139846
- Pages: 200
-
Format:
Report Overview
Germanys Oncological therapeutics market size stood at around USD 6.45 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
The cancer diagnostics and profiling markets are growing, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease.
Technological breakthroughs are creating numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy.
The rise in the geriatric population is further compounding the growing demand for malignancy assays and the rapid market expansion.
Market Drivers
The driving factors for the growth of the cancer therapeutics market in Germany include:
- Ease in regulatory approval
- Increased healthcare spending for cancer
- Rising prevalence of cancer
- Strong R&D initiatives from key players
The direct cost of cancer has also increased, and thus, the cost of cancer drugs as a share of direct health costs has doubled. The increase in the cost of cancer treatment, along with drug prices, has resulted in the growth of the overall market. In addition, the heavy investments made in R&D activities have enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and a surge in cancer prevalence have boosted the market growth.
Epidemiology
New Cases in 2020
Breast Cancer cases (69,697) were seen to be the highest gaining 11% of the total cases observed in Germany followed by Prostate (67,959) and Lung Cancer (64,804) in the total cases (333,384) observed in 2020.
Breast Cancer is leading with its Incidence rates standing at 82.2 whereas Lung cancer has the highest mortality rate of 23.1
1. Germany Oncological Therapeutics Market Overview........................
A. Market Size
2. Market Growth Drivers.
A. Ease in regulatory approval
B. Increased healthcare spending for cancer
C. Rising prevalence of cancer
D. Strong R&D initiatives from key players
3. Epidemiology.........................................................................................................
A. Number of new cases in 2020
B. Incidence and Mortality Rates
4. Oncological Therapeutics Market Segmentation........................
A. Cancer Type
a. Breast cancer
b. Lung cancer
c. Colorectal cancer
d. Ovarian cancer
e. Blood Cancer
f. Others
B. Treatment Type
a. Chemotherapy
b. Target Therapy
c. Immunotherapy
d. Hormonal Therapy
C. End Users
a. Hospitals
b. Specialty Clinics
c. Cancer and Radiation Therapy Centres
5. Oncological Major Products Market Share
A. Market Analysis, Insights and Forecast By Revenue
6. Competitive Landscape...
A. Major Players
B. Products in Pipeline
7. Key Company Profiles..
A. QIAGEN N.V. Company overview, Product & Services, Strategies & Financials
B. Becton Dickinson Company overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth
A. New Trends and Development of Dermatology drug market
B. Future Opportunities
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
